a KC
Generic Name: lopinavir/ritonavir
Pill imprint a KC has been identified as Kaletra 100 mg-25 mg.
Kaletra is used in the treatment of hiv infection; nonoccupational exposure and belongs to the drug class protease inhibitors. Risk cannot be ruled out during pregnancy.
Kaletra 100 mg-25 mg is not subject to the Controlled Substances Act.
See also related documents.
Kaletra Images
- Generic Name:
- lopinavir/ritonavir
- Imprint:
-
a KC
- Strength:
- 100 mg-25 mg
- Color:
- Yellow
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- copovidone
sorbitan monolaurate
silicon dioxide colloidal
sodium stearyl fumarate
titanium dioxide
magnesium silicate
polyethylene glycol 3350
ferric oxide yellow
- Drug Class:
- Protease inhibitors
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Abbott Laboratories
- National Drug Code (NDC):
- 00074-0522
| NDC Code | Manufacturer / Repackager |
|---|---|
| 35356-0111 | Lake Erie Medical and Surgical Supply (repackager) |
| 52959-0968 | H.J. Harkins Company, Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Kaletra resources
- Kaletra
- Kaletra (Wolters Kluwer)
- Kaletra Capsules (Wolters Kluwer)
- Kaletra Solution (Wolters Kluwer)
- Kaletra (Cerner Multum)
- Kaletra (Micromedex) - Includes Dosage Information
- Kaletra (AHFS DI)
- Kaletra (FDA)
- Kaletra Oral Solution (FDA)
Search Again
